EP Patent

EP0654264A1 — Treatment of incontinence with venlafaxine or an aryloxy propanamine compound

Assigned to Eli Lilly and Co · Expires 1995-05-24 · 31y expired

What this patent protects

Urinary incontinence in humans is treated by administration of venlafaxine or a compound chosen from a series of aryloxy propanamines.

USPTO Abstract

Urinary incontinence in humans is treated by administration of venlafaxine or a compound chosen from a series of aryloxy propanamines.

Drugs covered by this patent

Patent Metadata

Patent number
EP0654264A1
Jurisdiction
EP
Classification
—
Expires
1995-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.